Expansion Through Partnerships Recent collaborations with Buy-Supply Corp and Nissco LLC demonstrate Novalent's strategic efforts to broaden distribution channels, creating opportunities to introduce their long-lasting germ protection technology across various markets and customer segments.

Innovative Technology Adoption Novalent's patented non-toxic antimicrobial layer offers a compelling value proposition for organizations seeking effective, long-lasting surface and skin protection solutions, making it a strong candidate for partnerships with companies prioritizing hygiene and sanitation.

Strong Market Presence With a client list that includes major brands like PepsiCo and HanesBrands, Novalent has established credibility and an extensive network in the consumer goods industry, opening avenues for sales to other large-scale manufacturing and retail enterprises.

Funding and Growth Potential Having raised $11 million from a diverse investor base and generating revenues between $1 million and $10 million, Novalent is positioned for scaling operations and expanding its sales footprint in both domestic and international markets.

Leadership & Innovation The appointment of Harvard Business School Professor Joshua D. Margolis to its advisory board signals a focus on strategic growth and innovation, which can attract additional clients interested in cutting-edge antimicrobial solutions and strengthen sales narratives around technological leadership.